Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE)

CUSIP: 22978P106

Q4 2019 13F Holders as of 31 Dec 2019

Type / Class
Equity / Common Stock, $0.001 par value per share
Shares outstanding
43,411,663
Total 13F shares
10,554,208
Share change
+3,931,445
Total reported value
$167,568,706
Price per share
$15.88
Number of holders
60
Value change
+$63,118,277
Number of buys
42
Number of sells
14

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 22978P106?
CUSIP 22978P106 identifies CUE - Cue Biopharma, Inc. - Common Stock, $0.001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of CUE - Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Nantahala Capital Management, LLC
13F
Company
3.2%
1,378,198
$11,618,000 30 Sep 2019
13F
BlackRock Finance, Inc.
13F
Company
2.8%
1,221,270
$10,295,000 30 Sep 2019
13F
Slate Path Capital LP
13F
Company
2.1%
890,000
$7,503,000 30 Sep 2019
13F
VANGUARD GROUP INC
13F
Company
1.7%
755,152
$6,366,000 30 Sep 2019
13F
683 Capital Management, LLC
13F
Company
0.69%
300,000
$2,529,000 30 Sep 2019
13F
STATE STREET CORP
13F
Company
0.66%
285,929
$2,410,000 30 Sep 2019
13F
NORTHERN TRUST CORP
13F
Company
0.52%
223,652
$1,886,000 30 Sep 2019
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.49%
210,734
$1,776,000 30 Sep 2019
13F
Nuveen Asset Management, LLC
13F
Company
0.16%
69,954
$590,000 30 Sep 2019
13F
HSBC HOLDINGS PLC
13F
Company
0.16%
68,146
$574,000 30 Sep 2019
13F
Sigma Planning Corp
13F
Company
0.14%
60,210
$508,000 30 Sep 2019
13F
Bank of New York Mellon Corp
13F
Company
0.13%
56,099
$473,000 30 Sep 2019
13F
STIFEL FINANCIAL CORP
13F
Company
0.13%
55,855
$471,000 30 Sep 2019
13F
SPHERA FUNDS MANAGEMENT LTD.
13F
Company
0.12%
50,000
$422,000 30 Sep 2019
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.11%
48,646
$411,000 30 Sep 2019
13F
UBS Group AG
13F
Company
0.11%
48,513
$409,000 30 Sep 2019
13F
Rock Creek Group, LP
13F
Company
0.1%
42,505
$358,000 30 Sep 2019
13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
13F
Company
0.07%
30,549
$258,000 30 Sep 2019
13F
MORGAN STANLEY
13F
Company
0.07%
28,515
$240,000 30 Sep 2019
13F
STRS OHIO
13F
Company
0.06%
28,200
$237,000 30 Sep 2019
13F
WELLS FARGO & COMPANY/MN
13F
Company
0.06%
26,945
$227,000 30 Sep 2019
13F
OXFORD ASSET MANAGEMENT LLP
13F
Company
0.06%
26,602
$224,000 30 Sep 2019
13F
RHUMBLINE ADVISERS
13F
Company
0.05%
23,630
$199,000 30 Sep 2019
13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE
13F
Company
0.03%
14,549
$129,000 30 Sep 2019
13F
CITIGROUP INC
13F
Company
0.03%
14,340
$121,000 30 Sep 2019
13F
BARCLAYS PLC
13F
Company
0.03%
14,235
$120,000 30 Sep 2019
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.03%
13,925
$117,000 30 Sep 2019
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.03%
13,103
$111,000 30 Sep 2019
13F
AMERICAN INTERNATIONAL GROUP, INC.
13F
Company
0.03%
12,379
$104,000 30 Sep 2019
13F
Parian Global Management LP
13F
Company
0.03%
11,000
$93,000 30 Sep 2019
13F
NEW YORK STATE COMMON RETIREMENT FUND
13F
Company
0.02%
10,800
$91,000 30 Sep 2019
13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC
13F
Company
0.02%
10,072
$85,000 30 Sep 2019
13F
Russell Investments Group, Ltd.
13F
Company
0.02%
7,942
$67,000 30 Sep 2019
13F
JPMORGAN CHASE & CO
13F
Company
0.01%
6,427
$54,000 30 Sep 2019
13F
DEUTSCHE BANK AG\
13F
Company
0.01%
5,760
$46,000 30 Sep 2019
13F
Legal & General Group Plc
13F
Company
0.01%
3,527
$30,000 30 Sep 2019
13F
VICTORY CAPITAL MANAGEMENT INC
13F
Company
0.01%
3,480
$29,000 30 Sep 2019
13F
BNP PARIBAS FINANCIAL MARKETS
13F
Company
0.01%
2,943
$24,809 30 Sep 2019
13F
BANK OF MONTREAL /CAN/
13F
Company
0.01%
2,344
$19,000 30 Sep 2019
13F
D'Orazio & Associates, Inc.
13F
Company
0%
2,000
$17,000 30 Sep 2019
13F
Ameritas Investment Partners, Inc.
13F
Company
0%
1,576
$13,000 30 Sep 2019
13F
MEEDER ASSET MANAGEMENT INC
13F
Company
0%
590
$5,000 30 Sep 2019
13F
Tower Research Capital LLC (TRC)
13F
Company
0%
501
$4,000 30 Sep 2019
13F
LADENBURG THALMANN FINANCIAL SERVICES INC.
13F
Company
0%
120
$1,000 30 Sep 2019
13F

Institutional Holders of Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) as of Q4 2019

As of 31 Dec 2019, Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) was held by 60 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 10,554,208 shares. The largest 10 holders included Avoro Capital Advisors LLC, Nantahala Capital Management, LLC, BlackRock Inc., Slate Path Capital LP, VANGUARD GROUP INC, MANGROVE PARTNERS, STATE STREET CORP, 683 Capital Management, LLC, Corriente Advisors, LLC, and Crestwood Advisors Group LLC. This page lists 60 institutional shareholders reporting positions in this security for the Q4 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2019 vs Q3 2019 Across Filers

Q3 2019 holders
44
Q4 2019 holders
60
Holder diff
16
Investor Q3 2019 Shares Q4 2019 Shares Share Diff Share Chg % Q3 2019 Value $ Q4 2019 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.